Success in preparing new vaccines for laboratories

More than 1,000 scientists gathered in Cancun, Mexico over the weekend to discuss tuberculosis prevention drugs and vaccines, which killed more than 1.8 million people in 2008, and 1 person dies every 20 seconds from this disease.

Doctor Ann Wajja, the lead researcher in Uganda, said: "Three out of eight vaccines being tested clinically, including moxifloxacin, have good results when applied to tuberculosis patients." This vaccine can shorten the duration of treatment from 6 months to 4 months and is expected to be produced within the next 5 years.

Although TB ​​is a dangerous infectious disease, so far only one vaccine, Bacille Calmette Guerin (BCG) has been invented since 1920, but its applicability is not high. This vaccine works to prevent younger children from adults.

According to the Vaccine Study of Global Tuberculosis Prevention, 4 out of 8 vaccines being tested in clinical trials not only prevent TB infection of all ages but also prevent its effects on patients. HIV infection and drug-resistant TB patients.